These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 19276256

  • 1. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner.
    Wu XX, Kakehi Y.
    Clin Cancer Res; 2009 Mar 15; 15(6):2039-47. PubMed ID: 19276256
    [Abstract] [Full Text] [Related]

  • 2. Low concentrations of doxorubicin sensitizes human solid cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-receptor (R) 2-mediated apoptosis by inducing TRAIL-R2 expression.
    Wu XX, Jin XH, Zeng Y, El Hamed AM, Kakehi Y.
    Cancer Sci; 2007 Dec 15; 98(12):1969-76. PubMed ID: 17922852
    [Abstract] [Full Text] [Related]

  • 3. Delineation of apoptotic genes for synergistic apoptosis of lexatumumab and anthracyclines in human renal cell carcinoma cells by polymerase chain reaction array.
    Jin X, Wu XX, Jin C, Inui M, Sugimoto M, Kakehi Y.
    Anticancer Drugs; 2012 Apr 15; 23(4):445-54. PubMed ID: 22205156
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of death receptor 4 mediated apoptosis and cytotoxicity in renal cell carcinoma cells by subtoxic concentrations of doxorubicin.
    Jin X, Wu XX, Abdel-Muneem Nouh MA, Kakehi Y.
    J Urol; 2007 May 15; 177(5):1894-9. PubMed ID: 17437844
    [Abstract] [Full Text] [Related]

  • 5. Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model.
    Zhang L, Zhang X, Barrisford GW, Olumi AF.
    Cancer Lett; 2007 Jun 18; 251(1):146-57. PubMed ID: 17184908
    [Abstract] [Full Text] [Related]

  • 6. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
    Mizutani Y, Nakao M, Ogawa O, Yoshida O, Bonavida B, Miki T.
    J Urol; 2001 Jan 18; 165(1):263-70. PubMed ID: 11125422
    [Abstract] [Full Text] [Related]

  • 7. Human agonistic antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 induces cytotoxicity and apoptosis in prostate cancer and bladder cancer cells.
    Shimada O, Wu X, Jin X, Nouh MA, Fiscella M, Albert V, Matsuda T, Kakehi Y.
    Urology; 2007 Feb 18; 69(2):395-401. PubMed ID: 17320696
    [Abstract] [Full Text] [Related]

  • 8. Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels.
    Nawrocki ST, Carew JS, Douglas L, Cleveland JL, Humphreys R, Houghton JA.
    Cancer Res; 2007 Jul 15; 67(14):6987-94. PubMed ID: 17638911
    [Abstract] [Full Text] [Related]

  • 9. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
    Reddy RM, Tsai WS, Ziauddin MF, Zuo J, Cole GW, Maxhimer JB, Fang B, Schrump DS, Nguyen DM.
    J Thorac Cardiovasc Surg; 2004 Dec 15; 128(6):883-91. PubMed ID: 15573073
    [Abstract] [Full Text] [Related]

  • 10. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M, Strohecker A, Chen F, Kwan T, Bosman J, Jordan VC, Cryns VL.
    Clin Cancer Res; 2008 May 15; 14(10):3168-76. PubMed ID: 18483385
    [Abstract] [Full Text] [Related]

  • 11. Bortezomib sensitizes non-Hodgkin's lymphoma cells to apoptosis induced by antibodies to tumor necrosis factor related apoptosis-inducing ligand (TRAIL) receptors TRAIL-R1 and TRAIL-R2.
    Smith MR, Jin F, Joshi I.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 2):5528s-5534s. PubMed ID: 17875785
    [Abstract] [Full Text] [Related]

  • 12. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY, Kim MJ, Chung HY, Lee SJ, Jang YJ.
    Oncol Rep; 2007 Jan 15; 17(1):175-84. PubMed ID: 17143496
    [Abstract] [Full Text] [Related]

  • 13. Synergistic induction of apoptosis by mapatumumab and anthracyclines in human bladder cancer cells.
    Ahmed SM, Wu X, Jin X, Zhang X, Togo Y, Suzuki T, Li Y, Kanematsu A, Nojima M, Yamamoto S, Sugimoto M, Kakehi Y.
    Oncol Rep; 2015 Feb 15; 33(2):566-72. PubMed ID: 25483927
    [Abstract] [Full Text] [Related]

  • 14. Augmented antitumor activity against B-cell lymphoma by a combination of monoclonal antibodies targeting TRAIL-R1 and CD20.
    Maddipatla S, Hernandez-Ilizaliturri FJ, Knight J, Czuczman MS.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4556-64. PubMed ID: 17671142
    [Abstract] [Full Text] [Related]

  • 15. Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells.
    Zhang X, Li W, Olumi AF.
    Clin Cancer Res; 2007 Dec 01; 13(23):7181-90. PubMed ID: 18056199
    [Abstract] [Full Text] [Related]

  • 16. Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells.
    Shi J, Shen HM.
    Biochem Pharmacol; 2008 May 01; 75(9):1729-42. PubMed ID: 18377873
    [Abstract] [Full Text] [Related]

  • 17. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug 01; 160(2):561-70. PubMed ID: 9679929
    [Abstract] [Full Text] [Related]

  • 18. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
    Park SJ, Kim MJ, Kim HB, Sohn HY, Bae JH, Kang CD, Kim SH.
    Biochem Pharmacol; 2009 Apr 15; 77(8):1328-36. PubMed ID: 19426671
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
    Wu XX, Mizutani Y, Kakehi Y, Yoshida O, Ogawa O.
    Cancer Res; 2000 Jun 01; 60(11):2912-8. PubMed ID: 10850437
    [Abstract] [Full Text] [Related]

  • 20. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
    Hougardy BM, van der Zee AG, van den Heuvel FA, Timmer T, de Vries EG, de Jong S.
    Gynecol Oncol; 2005 May 01; 97(2):353-64. PubMed ID: 15863130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.